PTC
AMRX icon

Petrus Trust Company’s Amneal Pharmaceuticals AMRX Stock Holding History

Petrus Trust Company’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-35,962
Closed -$360K – 37
2025
Q3 		$360K Sell
35,962
-41,141
-53% -$369K 0.04% 32
2025
Q2 		$624K Buy
77,103
+16,128
+26% +$122K 0.06% 62
2025
Q1 		$511K Hold
60,975
– – 0.05% 181
2024
Q4 		$483K Buy
+60,975
New +$512K 0.05% 226
2022
Q4 		– Sell
-12,652
Closed -$26K – 473
2022
Q3 		$26K Hold
12,652
– – ﹤0.01% 235
2022
Q2 		$40K Buy
+12,652
New +$45.8K 0.01% 131

Other funds holding AMRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Petrus Trust Company's AMRX Position: Q4 2025 in Review

Petrus Trust Company sold out of Amneal Pharmaceuticals (AMRX) in Q4 2025, closing a stake of 35,962 shares — an estimated $360K sold.

Petrus Trust Company first reported a position in AMRX in Q2 2022 and held it in 6 quarters. The position peaked at $624K in Q2 2025. 277 funds tracked by Wall St. Rank hold AMRX as of Q4 2025.

  • Petrus Trust Company reported no remaining Amneal Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Petrus Trust Company sold 35,962 Amneal Pharmaceuticals shares in Q4 2025, an estimated $360K.
  • Petrus Trust Company first reported a position in Amneal Pharmaceuticals in Q2 2022 and held it in 6 quarters.
  • Petrus Trust Company's Amneal Pharmaceuticals position peaked at $624K in Q2 2025.
  • 277 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q4 2025.

Based on Petrus Trust Company's 13F filing for Q4 2025, filed 17 Feb 2026.